The beta-adrenergic receptor in pulmonary arterial hypertension: a novel therapeutic target?

@article{Rubin2015TheBR,
  title={The beta-adrenergic receptor in pulmonary arterial hypertension: a novel therapeutic target?},
  author={Lewis J. Rubin},
  journal={Journal of the American College of Cardiology},
  year={2015},
  volume={65 7},
  pages={681-3}
}
SEE PAGE 668 C onsiderable success has been achieved in the treatment of pulmonary arterial hypertension (PAH) over the past 15 years, with 9 drugs approved by the U.S. Food and Drug Administration and other regulatory agencies worldwide for use by several different modes of delivery and lung transplantation becoming an option for patients refractory tomedical therapy (1). Quality of life and survival rates are improved, and recent studies have shown that newer therapies also reduce the risk of… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 17 references

[Updated treatment algorithm of pulmonary arterial hypertension].

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir • 2014
View 1 Excerpt

Similar Papers

Loading similar papers…